The U.S. Food and Drug Administration approved a heart analysis system to help diagnose pulmonary arterial hypertension, one of the complications that can arise from lupus.
PAH is the most serious form of the five recognized groups of pulmonary hypertension. Most patients with PAH are diagnosed too late for treatment to be fully effective. “With increasing availability of effective therapies, and evidence-based treatment guidelines recommending frequent monitoring, functional tests should prove invaluable for managing patients with PAH.”
Source: Ventripoint Diagnostics Ltd Press Release